Related Experiment Video
Updated: Jun 17, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD
S George1, E J Mufson, S Leurgans
1Department of Neurological Sciences, Rush University Medical Center, 1653 W. Congress Parkway, Chicago, IL 60612, United States.
Abstract:
The substantia innominata (SI) contains the nucleus basalis of Meynert, which provides the major cholinergic innervation to the entire cortical mantel and the amygdala; degeneration of nucleus basalis neurons correlates with cognitive decline in Alzheimer's disease (AD). However, whether SI atrophy occurs in individuals with amnestic mild cognitive impairment (aMCI) has not been examined thoroughly in vivo. In the present study, we developed a new protocol to measure volumetric changes in the SI from magnetic resonance imaging (MRI) scans. Participants consisted of 27 elderly controls with no cognitive impairment (NCI); 33 individuals with aMCI; and 19 patients with mild AD. SI volumes were traced on three consecutive gapless 1mm thick coronal slices. Results showed that SI volume was significantly reduced in the mild AD group compared to both NCI and aMCI participants; however, the NCI and aMCI groups did not differ from each other. Furthermore, a decrease in SI volume was related to impaired performance on declarative memory tasks even when attention was controlled.
Insights
Substantia innominata (SI) volume reduction is linked to Alzheimer's disease (AD) but not mild cognitive impairment (MCI). This study measured SI atrophy in NCI, aMCI, and AD individuals using MRI scans.
Area of Science:
- Neuroimaging
- Neurodegeneration
- Cognitive Neuroscience
Background:
- The substantia innominata (SI) is crucial for cholinergic innervation, with its neuron degeneration linked to Alzheimer's disease (AD) cognitive decline.
- Previous research has not thoroughly investigated SI atrophy in vivo for individuals with amnestic mild cognitive impairment (aMCI).
Purpose of the Study:
- To develop and apply a novel magnetic resonance imaging (MRI) protocol for measuring volumetric changes in the substantia innominata (SI).
- To examine SI atrophy in individuals with no cognitive impairment (NCI), aMCI, and mild AD.
Main Methods:
- A new protocol was developed to measure volumetric changes in the SI using MRI scans.
- SI volumes were traced on three consecutive gapless 1mm thick coronal slices.
- Participants included 27 NCI, 33 aMCI, and 19 mild AD individuals.
Main Results:
- SI volume was significantly reduced in the mild AD group compared to both NCI and aMCI groups.
- No significant difference in SI volume was found between the NCI and aMCI groups.
- Reduced SI volume correlated with impaired declarative memory performance, even after controlling for attention.
Conclusions:
- Substantia innominata (SI) atrophy is a characteristic of mild Alzheimer's disease (AD) but not amnestic mild cognitive impairment (aMCI).
- SI volume reduction is associated with memory deficits, highlighting its role in cognitive decline.
More Related Videos
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies for Cardiovascular System IV: CMRI

